KaloBios Exodus Continues With Two More Board Member Departures

  • Former CEO Shkreli has denied wrongdoing in fraud case
  • Fernandez, Biestek depart, leaving board with two directors

Martin Shkreli Case Holds Mirror to Pharma Business

Two more KaloBios Pharmaceuticals Inc. board members resigned, continuing the exodus from the company previously run by Martin Shkreli after his arrest on securities fraud charges related to another drugmaker.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.